Market Tracker

09/26 5:16pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

88.29
Delayed Data
As of 3:59pm ET
 -2.34 / -2.58%
Today’s Change
75.90
Today|||52-Week Range
134.71
-29.83%
Year-to-Date

Today’s Trading

Previous close90.63
Today’s open90.00
Day’s range88.10 - 91.23
Volume1,608,081
Average volume (3 months)1,398,943
Market cap$22.5B
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+187.39%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book23.75

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.88-2.09%
ZTSZoetis Inc-0.30-0.58%
BAXBaxter International...-0.29-0.61%
INCYIncyte Corp-0.22-0.25%
Data as of 4:02pm ET, 09/26/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.26
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts